July 22, 2026 | Korea Scales Up

Issue #45 · July 22

View Archive | Subscribe | Partners With Us

From Members to Global: Covering the Entire Bio Industry

Korea scales up with bold investment, global partnerships and AI-powered innovation!🚀

This week's edition features Korea's biggest biotech moves—from a landmark acquisition and a ₩1 trillion mega-fund to cross-border collaborations and next-generation AI innovation.

Stay tuned till the end for more K-Bio updates!

THIS WEEK:

Samsung Biologics spreads wings with proposed $1.8B acquisition of Swiss CDMO

South Korean contract manufacturer Samsung Biologics hopes to tap into the booming peptide production and weight loss market with plans to buy out Switzerland-based CDMO PolyPeptide for $1.8 billion.— Fierce Pharma

Korea to Create 1 Trillion Won Mega-Fund for Pharma-Bio Global Top 5 Push The Ministry of Health and Welfare (MOHW) will create a 1 trillion won "mega-fund" to help Korea's pharmaceutical and biotech industry become a global top-five player. — Seoul Economic Daily

KoreaBIO seeks closer biotech ties with Taiwan At the conference held in Taipei from July 15 to 19, KoreaBIO co-hosted the Korea Session to showcase the country's biotech ecosystem and promote greater open innovation between the two economies. — The Korea Herald

KoreaBIO MEMBER NEWS

#New #Welcome

Welcome on board, Asleep! 💼🤝

Specializing in AI-based digital healthcare and Software as a Medical Device (SaMD) development, Asleep has joined us as a new member company.

Progeneer Signs Up to $390 Million Cancer Vaccine Platform Licensing Deal with U.S. Biotech Company.

ACROBiosystems to Host July 31 Webinar on "Advancing Infectious Disease Research: From Host-Pathogen Interactions to Innovative Therapeutic Strategies".

Dt&CRO Vice President Kim Bong-tae Calls for Integrated Regulatory and Market Strategies Centered on Improved and Combination Drugs.

Neurophet’s ‘Neurophet AQUA AD Plus’ Designated as Innovative Product by Korea’s Ministry of Trade, Industry and Resources.

C&R Research Aims to Become a Data-Centered Global CRO, Highlighting Data and AI as Core Competitive Advantages.

👥 View More Members Companies

WHAT WE'VE BEEN UP TO

Highlights

KoreaBIO, in partnership with KOAT, held the Green Bio Industry Development Forum as part of AFPRO 2026! The forum brought together experts from government, industry, and academia to discuss strategies for advancing Korea’s green bio industry.